The novel SPPARM YR3–16 ameliorates metabolic disorders in vivo and attenuates adipocyte inflammation in vitro via PPARγ-dependent ERK suppression

International Immunopharmacology 2026

View at publisher

Authors: Cunyu Feng, Quan Liu, Jun Peng, Chunming Jia, Xuan Pan, Shuainan Liu, Xiaohui Geng, Jiayu Zhai, Min Wu, Siming Hao, Liran Lei, Liran Lei

+7 more

Kejia Xu, Yuting Ma, Lei Lei, Lei Lei, Zhanzhu Liu, Yi Huan, Zhufang Shen

DOI: 10.1016/j.intimp.2026.116320

Cited by: 1

References: 36

Fields of Study & Subjects

Peroxisome Proliferator-Activated Receptors Adipokines Inflammation and Metabolic Diseases Adipose Tissue and Metabolism

References 36